clofibric acid has been researched along with Adult Fanconi Syndrome in 1 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Portilla, D | 1 |
| Li, S | 1 |
| Nagothu, KK | 1 |
| Megyesi, J | 1 |
| Kaissling, B | 1 |
| Schnackenberg, L | 1 |
| Safirstein, RL | 1 |
| Beger, RD | 1 |
1 other study available for clofibric acid and Adult Fanconi Syndrome
| Article | Year |
|---|---|
Metabolomic study of cisplatin-induced nephrotoxicity.
Topics: Acute Kidney Injury; Animals; Antineoplastic Agents; Cisplatin; Clofibric Acid; Fanconi Syndrome; Fa | 2006 |